Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: systematic review.
The use of the highly effective Haemophilus influenzae type b (Hib) conjugate vaccine has increased globally. We review the benefits and limitations of studies measuring Hib vaccine effectiveness (VE). We critically examine the case-control approach by assessing the similarities and differences in methodology and findings and discuss the need for future Hib VE studies. In the absence of good surveillance data, vaccine effectiveness studies can play an important role, particularly with the increasing use of pneumococcal vaccine that has not been well tested under field conditions in less developed countries. However, the effectiveness of Hib vaccine has been well documented so the need for future VE Hib studies is minimal.
O'Loughlin
Rosalyn E
RE
London School of Hygiene and Tropical Medicine, London, UK. rosoloughlin@gmail.com
Edmond
Karen
K
Mangtani
Punam
P
Cohen
Adam L
AL
Shetty
Sharmila
S
Hajjeh
Rana
R
Mulholland
Kim
K
D016667:Bacterial Capsules / Q000276:immunology*; D016022:Case-Control Studies; D006192:Haemophilus Infections / Q000453:epidemiology / Q000517:prevention & control*; D018073:Haemophilus Vaccines / Q000276:immunology*; D006801:Humans; D018074:Vaccines, Conjugate / Q000276:immunology
D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D018074:Vaccines, Conjugate